Who Should Not Have Morpheus8: Contraindications Explained

Most pages about this treatment give contraindications two lines: pregnancy, pacemakers, active infection, ask your practitioner. The real list runs to several dozen items, and most of it is temporary. There is a large difference between “you cannot have this” and “not for another three months”, and it matters if you have had filler, a peel, isotretinoin or facial surgery in the past year. What follows is that list as the manufacturer and the regulator write it, grouped so you can find yourself in it.

There are two lists, and they are not the same

Any screening form traces back to one of two documents, and it is worth knowing which. The first is the Morpheus8 operator manual, InMode’s own instructions for use, which is the authoritative source for this device: the depths, the energy caps and the waiting intervals are the manufacturer’s own numbers for its own machine.

The second is the FDA’s contraindication list for microneedling devices as a class, which is noticeably wider. The two overlap on the obvious items: isotretinoin within the past 6 months, pregnancy and breastfeeding, keloid scars or a history of them, bleeding disorders and anticoagulant use, immunosuppression, uncontrolled diabetes, active skin infection or a cold sore outbreak, and caution in darker skin types.

The class list adds entries the manual does not name: hepatitis or HIV, eczema, psoriasis, vitiligo and autoimmune disease, warts, moles or birthmarks in the treatment area, actinic keratoses, recent or planned sun exposure, and allergy to stainless steel or to anaesthetics. That last one is easy to skim past and matters, because topical anaesthetic is routine here and is part of why the treatment is tolerable at all. Neither list is wrong, but they are not interchangeable.

The device-related exclusions, which are the absolute ones

This is the shortest group and the firmest. Morpheus8 delivers bipolar radiofrequency at 1 MHz, passing current through tissue between pairs of needles, so anything in the body that conducts or responds to that current is a problem.

The manual lists a pacemaker, an internal defibrillator, or any other metallic or electronic implant anywhere in the body. Read that carefully: it is not restricted to the treatment area. A metal plate in your ankle counts as much as anything in your chest. Cochlear implants get their own instruction, that the handpiece stays at least 1 cm away.

Permanent implants in the treated area are contraindicated too, and the manual names metal plates, screws, piercings and silicone, with one exception: implants deep in the periosteal plane, against bone, may be treated over. If any of this applies to you, it is the end of the conversation rather than a discussion about settings.

Medical history, where most of the nuance lives

The list here is broad, and several entries hinge on a single qualifying word. Current or previous skin cancer, any other cancer, or pre-malignant moles are contraindicated. So are pregnancy and nursing, and an impaired immune system, whether from HIV or AIDS or from immunosuppressive medication. Severe concurrent conditions are listed too, cardiac disorders and sensory disturbances among them.

Endocrine disorders including diabetes, thyroid dysfunction and hormonal virilisation are listed as poorly controlled, which is the qualifying word: well-controlled disease is a conversation, not an automatic exclusion. Bleeding history is tighter. A history of bleeding coagulopathies is a contraindication, and so is anticoagulant use within the last 10 days, though that is a date rather than a bar, and never one to move by stopping a prescribed medicine yourself.

Recurrent herpes simplex in the treatment area is the entry people misread as a ban. The manual’s instruction is to treat only under a prophylactic regime, and the independent systematic review of this device class lists herpes prophylaxis among its key risks. If you get cold sores, say so, and expect antiviral cover rather than a refusal. One smaller item, easily missed: no NSAID use in the week before and after each session, at the practitioner’s discretion.

Skin conditions, and the state of your skin on the day

Some of this group is permanent and some of it is about the fortnight before your appointment. Any active skin condition in the treatment area rules the session out: sores, psoriasis, eczema, a rash. A history of keloids, of abnormal wound healing, or of very dry and fragile skin is a contraindication in its own right. The treatment works by injuring skin and relying on the healing that follows, so if your healing is atypical, the premise is too.

The manual also instructs that the device is not used over tattoos or permanent makeup you intend to keep, over the lips, or over hair-bearing surfaces. And excessively tanned or irritated skin, from sun, sunbeds or tanning products within the last two weeks, is a reason to postpone: entirely in your control, and the easiest way to lose a booked appointment.

Skin type, where the manual and the marketing diverge

InMode’s Australian marketing page presents the range as suitable for every Fitzpatrick type, up to and including VI. The company’s own operator manual is more careful: types V and dark VI should be treated with caution, energy above level 20 should not be used in types V to VI, and treatment should start at minimum energy and escalate by 5 levels per visit at 3 to 4 week intervals. Energy levels run from 5 to 60 on the standard and body tips, so that cap is a third of the range.

The FDA clearance adds a constraint from another direction, restricting energies above 62 mJ per pin to Fitzpatrick types I to IV. Review literature goes further, advising a 20 to 30 percent energy reduction in types IV to VI and avoiding the 0.5 mm resurfacing tip in V to VI.

None of that means deeper skin tones are excluded. It means lower energy, smaller increments, longer intervals and more sessions to get anywhere. A clinic that says skin type makes no difference to the protocol is not reading the manual it works from.

The timing list, which is where most people actually land

Almost everyone who thinks they are excluded lands here, in a group made of dates.

The filler row catches people, because filler is so common that many patients do not think of it as a procedure at all. Notice how the manual frames it: not by brand, not by a flat number of weeks, but by depth and by whether the product has gone. Superficial and intradermal product sits in exactly the tissue the needles are about to enter. Product placed deep against bone does not, which is why that wait is shorter.

So if you are 4 months past a filler appointment, you are not excluded, you are mid-interval. Bring the details: product, site, depth, date.

Why the screening matters more here than the category implies

Morpheus8 is 510(k) cleared, not FDA approved. Clearance is a substantial-equivalence pathway, a demonstration that a device resembles one already on the market, not a finding that it works. No Morpheus8 clearance names wrinkles, skin tightening, acne scars, cellulite, stretch marks, body contouring or fat reduction. The cleared wording covers electrocoagulation, haemostasis, and coagulation or contraction of soft tissue.

On 15 October 2025 the FDA published a safety communication on radiofrequency microneedling reporting burns, scarring, fat loss, disfigurement, nerve damage and the need for surgical repair, and stating that this is a medical procedure and not a cosmetic treatment. Two American specialist societies responded by urging practitioners to add those outcomes to their consent forms. The side effect picture is set out separately.

Set against that, no sham-controlled randomised trial of Morpheus8 has been published, and the one systematic review that excluded industry-funded studies rates the evidence base at Level of Evidence 5. That review also names the largest single source of complication risk, and it is not the machine: it is user error.

So the contraindication list is not defensive paperwork. It is the main published risk control this treatment has, and only as good as the person working through it.

What a proper consultation should ask you

This doubles as a test of the clinic. A consultation that does not cover the following has not screened you.

It should ask about implants anywhere in your body, take a full medication list with direct questions about anticoagulants in the last 10 days and isotretinoin in the last 6 months, and cover pregnancy, cancer history, diabetes and thyroid control, immune status, cold sores, and any keloid or slow-healing history.

Then the dates: every injectable in the area with its depth and timing, any facial surgery in the past year, any peel, laser or resurfacing, and any sun or sunbed exposure in the past fortnight. It should establish your Fitzpatrick type and say what energy plan follows. The manual asks for a test spot in an inconspicuous area before a first full session, so ask whether you will get one, and ask who will be holding the handpiece.

If anything on your own list needs diagnosing rather than treating, a mole you are unsure about, an undiagnosed rash, diabetes that is not well controlled, that belongs with your GP or a dermatologist first, and no aesthetic clinic should move past it. Once it is clear, book a consultation with us and we will work through the whole list, including the honest answer if the date you are waiting for is further off than you hoped.